Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
126 participants
OBSERVATIONAL
2023-10-05
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Bladder Underactivity on Treatment Outcomes of Laser Prostatectomy
NCT02243540
Storage Symptom After Laser Prostatectomy
NCT02073799
Effect of Laser Settings on Postoperative Voiding Symptoms in Patients Undergoing Holmium Laser Enucleation of the Prostate
NCT04699552
Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical Prostatectomy
NCT03061760
Benign Prostate Surgery and QOL and Sexual Function
NCT05826691
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bowel function post Holmium Laser Enucleation of the Prostate
Observing post operative bowel functions among participants who have undergone a HoLEP procedure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to read, understand, and complete patient questionnaires
* Willing to sign the informed consent form
Exclusion Criteria
* Patients with known neurogenic bowel
* Patients having concurrent ureteroscopy+/-laser lithotripsy, percutaneous nephrolithotomy, or non-urologic surgery at time of HoLEP
* Anticipated need for perineal urethrostomy at time of HoLEP
* Prior pelvic radiation or patients with history of bladder cancer with or without Bacillus Calmette-Guerin (BCG) therapy
* Patients who lack decisional capacity
18 Years
89 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amy Krambeck
Urologic Surgeon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern Medicine
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00220105
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.